熱門資訊> 正文
NOTV、BFRI和CPOP均为上市前输家
2024-05-10 20:30
- Losers: Macrogenics (MGNX) -68% after Q1 earnings release.
- Microvision (MVIS) -28% after Q1 earnings release.
- Progyny (PGNY) -26% after Q1 earnings release.
- Protalix BioTherapeutics (PLX) -18% after Q1 earnings release.
- Evolv Technologies Holdings (EVLV) -17% after Q1 earnings release.
- Biofrontera (BFRI) -15%.
- Applied Optoelectronics (AAOI) -14% after Q1 earnings release.
- Oklo (OKLO) -14%.
- JFrog Ltd (FROG) -12% after Q1 earnings release.
- Navitas Semiconductor Corp (NVTS) -10% after Q1 earnings release.
- Douglas Elliman (DOUG) -10% after Q1 earnings release.
- Pop Culture Group Co Ltd (CPOP) -9%.
- Telesis Bio (TBIO) -9% reports Q1 results.
- Akamai Technologies (AKAM) -9% after Q1 earnings release.
- NewGenIvf Group Ltd (NIVF) -8%.
- Indie Semiconductor (INDI) -7% after Q1 earnings release.
- Runway Growth Finance Corp (RWAY) -6%. announces secondary offering of common stock by selling stockholder.
- Allakos (ALLK) -5% after Q1 earnings release.
- Inotiv (NOTV) -5% reschedules its fiscal 2024 second Quarter results.
- Ryde Group Ltd. (RYDE) -5%.
More on pre-market losers & stocks.
- Inotiv Stock: Financial Turnaround Overshadowed By Animal Testing Controversies
- Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript
- Biofrontera stock soars on announcing private placement of up to $16M
- Seeking Alpha’s Quant Rating on Biofrontera
- Historical earnings data for Biofrontera
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
